RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

<<We are getting the downtick today that I thought we would.>>

Talk about the Dysphoria Express. With the Dow down over 400 points right now, and ten CNS companies down more percentage wise than Cortex is, it might be premature to accept any accolades for prescience.

I am truly baffled by the concept that it's hard to know whether to be positive or negative about Cortex at 1.67, because the case for Ampakines is not yet 'proven'. If the case for Ampakines were proven (what does that mean, PhIIb, Phase III, marketed product??), the stock would be 5-10 times higher than it is now, at least.

The valid question now is to ask--is there a probability that enough of Cortex's potential will be realized to justify the expectation that the share price will end up higher than it is now? There are no certainties, but in my view, there is a compelling case to be made for the probability.

But it is really absurd to attribute any specific meaning to Cortex's share price drop today given the carnage in the overall market--unless to conclude that, given how fast Cortex had risen of late, it is remarkable that it has held its price as well as it has today.

Addendum--now the Dow is 'only' down 360 points.

NeuroInvestment